The "Gold Sodium Thiosulfate (CAS 10233-88-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

Norgine Pharmaceuticals Ltd., has launched PEDMARQSI (sodium thiosulfate injection) in Germany. This marks a significant advancement in the global commercialization of the first approved therapy ...

This requires a conical flask and gas syringe. Sodium thiosulfate reacts with dilute hydrochloric acid to produce sodium chloride, water, sulfur dioxide and sulfur. The sulfur makes the solution ...

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.